PATENT CLAIM ANALYSIS

Application Number: 15766459
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to an anti-cancer vaccine combination. Particularly, the invention relates to a pharmaceutical combination comprising a PD-L1/PD-1 expression inhibitor in combination with a viral antigen-associated vaccine.

Claim (Index 11):
The method of  claim 8 , wherein the HPV-associated tumor is HPV-infected lung or cervical tumor.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 91.0
- Lexical Diversity: 1.40909
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14883557', '14163269', '14789226', '12213696', '15306289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7428332560911011
- 35 USC 102 Novelty (BERT): 0.5470560184242386
- Combined Prediction Score: 0.7232555323244149
- Mean Citation Score: 398.07744
- Max Citation Score: 414.82068
- Similarity Product: 292.2792293131256

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test